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Cardioversion of Atrial Flutter: Atrial Appendage
Stunning and Thromboembolic Potential. A
Transesophageal Echocardiographic Study
92% of patients demonstrated a reduction in LAA+; 58% of patients had
a greater than 50% decrease in LAA+. 50% of patients developed new or
increased spontaneous echo contrast after cardioversion. Both patients with
new cerebrovascular accidents demonstrated marked reductions in LAA+
and increased spontaneous echo contrast.
Conclusion: Patients undergoing CV of AFL have evidence of significant
left atrial appendage stunning. Stunning after CV as evidenced by decreased
left atrial appendage velocities and increased spontaneous echo contrast
is common and associated with thromboembolism. Anticoagulation should
be considered in patients undergoing CV of atrial flutter with high risk TEE
indices.
model for deterministic chaos using the Lorentz equations. Spectral analysis
demonstrated a mean Of of 6.3 ± 0.7 Hz (range 5.6-7.8 Hz) which was as-
sociated with a wide range of subharmonics (12% to 59% of total spectral
power, avg 32 ± 12%). Three patients exhibited very narrow based spec-
tral patterns with very little subharmonics. Twelve of 17 LAA Doppler fourier
spectra 171 %) could be defined by the equation mfl ± nf2' The transition
to a chaotic state was modeled by solving the Lorenz equations, with the
solutions and Fourier transform of the signal exhibiting striking similarity to
the signal generated by LAA Doppler flow as well as to the Fourier spectra
of LAA flow in AF.
Conclusions: (1) Fourier analysis of LAA Doppler flow in AF demonstrates
behavior consistent with deterministic chaos in most but not all cases. (2)
Mathematical modeling of a chaotic system closely resembles LAA flow in
AF Fourier analysis of LAA flow should provide insight into structural and
electrophysiologic mechanisms of AF
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Cardioversion (CV) of atrial arrhythmias is commonly performed. Pericar-
dioversion anticoagulation is not recommended in patients with atrial flut-
ter (AFL) as it is assumed that the thromboembolic potential of atrial flut-
ter is extremely low. To determine the thromboembolic potential of patients
with atrial flutter undergoing cardioversion, we performed transesophageal
echocardiography (TEE) in 26 consecutive patients (25 electrical and 1 pac-
ing) immediately prior to and immediately after cardioversion. 2 patients ex-
perienced cerebrovascular events within 24 hours of cardioversion despite
the absence of thrombi on the precardioversion TEE. Peak left atrial ap-
pendage outflow (LAA+) and inflow velocities (LAA-, cm/sec) prior to IPRE)
and after (POST) cardioversion were documented (mean ± SO):
Oi Ling Kwan, Bruno Cotter, Youngmei Cha, Shiro Nozaki, Constance Calisi,
Anthony N. DeMaria. University of California at San Diego, CA
OW3600 (EG) is a new perflourocarbon Idodecaflouropentane) ultrasonic
contrast agent capable of producing myocardial opacification by IV injection.
However, the doses required for myocardial visualization have sometimes
been associated with transient hemodynamic changes. Therefore, we eval-
uated the ability of pretreatment with: (1) antihistamines and corticosteroids
to eliminate hypersensitivity and thus reduce hemodynamic changes; and
(2) administration of coronary vasodilators to enhance myocardial intensity.
We performed 2-0 echo in the short axis parasternal view in 10 closed chest
ventilated dogs in whom LV, Ao and pulmonary artery catheters enabled di-
rect assessment of hemodynamics. All animals were given benadryl1 mglkg
and Solu-Mediol1 mglkg approximately one hour prior to the study. Subse-
quently, a 0.5 cclkg EchoGen® injection was repeated. Contrast intensity was
quantified by a 0.3 cm2 region of interest positioned in the midventricular
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Evidence of Deterministic Chaos in Atrial
Fibrillation as Demonstrated by Fourier Spectral
Analysis of Left Atrial Appendage Doppler Flow
CV N LA LAA
SCE SCE 12-31 SCE (+) (T) (IIIB-IV)
Unsuccessful 14 1.5± 1 71% 13 ± 0.9 26 54 74%
Successful 51 1.1 ± 1 43%* 0.9 ± 1.1 35 72 43%*
significantly associated with the qualitative grade of atrial smoke (p < 0.003).
Conclusions: 1) Analysis of IBS FFT spectra shows that atrial smoke is a
unique echocardiographic phenomenon, clearly distinguishable from either
artifact or tissue; 2) IBS intensity analysis and IBS FFT frequency analysis
each provide an objective quantitative measure of smoke which may serve
to assess thrombogenic potential and embolic risk in patients with sponta-
neous echo contrast.
Pre-cardioversion Transesophageal
Echocardiography as a Predictor of Unsuccessful
Electrical Cardioversion of Atrial Fibrillation
LA spontaneous echo contrast grade 2-3 andlor LAA IIIB-IV flow pattern
had a diagnostic sensibility of 79%, specificity 60%, positive predictive value
35%, and negative 91 % for unsuccessful CV
Conclusions: TEE performed pre-CV is useful in detecting patients with
higher probability of unsuccessful CV Higher LA disfunction with sponta-
neous echo contrast grade 2-3 and/or higher LAA mechanical disfunction
(IIIB-IV) with spontaneous echo contrast grade 2-3, was found in this group
of patients. All this can be helpful to select patients for CV
Fernando Olaz, Nuria Basterra, Jesus Berj6n, Jose R. Carmona, Miguel Aleu,
Cesar Maravf, Cristina Elorz, Enrique de los Arcos. Hospital ofNavarra, Pamplona,
Spain
To assess the utility of transesophageal echocardiography (TEE) pre-
cardioversion (CV) of atrial fibrillation (AF) as a predictor of unsuccessful CV
(no reversion or recurrence <24 h.). 68 patients with AF and atrial flutter (8)
were studied. Mean aged was 61 ± 9 years. TEE was performed before CV
Left atrial (LA) and left atrial appendage (LAA) size, spontaneous echo con-
trast (SCE) grade (from 0 to 3) and mechanical function were evaluated. We
measured LAA emptying velocities (+) and total wave velocity (T = emptying
+ filling waves). LAA flow was classified in 6 patterns (lA, IB, II, lilA, IIIB, IV):
detected in sinus rhythm II), flutter (II). AF (III). and no identifiable flow waves
(IVI. The patterns IB, IIIB, and IV represented LAA mechanical disfunction,
and were defined by an emptying wave less than 20 cm/sec.
Results: 14 patients had recurrent AF 24 h. after CV The remaining pa-
tients were in sinus rhythm. There were no differences between both groups
with regard to aged, mitral stenosis prevalence, functional class, atrial flut-
ter, LA size and LAA dimension and history of embolization. In contrast, the
unsuccessful group had longer duration of AF, higher SEC grade and higher
mechanical disfunction.
*p < 0.05
Richard A. Grimm, Shalabh Chandra, Dominic Leung, Allan L. Klein, William
J. Stewart, James D. Thomas. The Cleveland Clinic Founda~'on, Cleveland, Ohio
Theories of deterministic chaos have been applied to mammalian systems
and specifically to arrhythmogenesis however controversy persists as to
whether fibrillation [atrial (AF) or ventricular] obeys the laws of dynamical
chaos. We addressed this question by analyzing the frequency spectra of left
atrial appendage (LAA) Doppler flow in AF (n = 17). describing these spectra
using fractions or multiples of the dominant frequency (Of) or by a func-
tion of two basic frequencies (f) along with their harmonics and frequency
combinations Imfl ± nf21, and correlating these signals with a mathematical
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wall and peak videointensity (PVI) was measured in gray levels. Results * =
p < 0.01 for EG vs DIP + EG.
HR FA(S) FA (D) LV PA PVI
BASE 145 ± 23 172 ± 14 120 ± 7 165 ± 12 122 ± 6 23 ± 18
EG 150 ± 24 163 ± 13 114±7 159 ± 13 28± 10 69 ± 50
DIP 142 ± 19 171 ± 14 114 ± 15 162 ± 23 24 ± 3 33 ± 21
DIP + EG 145 ± 23 156 ± 31 99 ± 21 145 ± 32 32 ± 4 110 ± 41
1. Anteroseptal
2. Anterior
3. Lateral
4. Posterolateral
5. Inferior
6. Posteroseptal
Pre-Occlusion
46.65 ± 7.01
3248 ± 1260
15.12 ± 4.39
12.13 ± 377
23.59 ± 4.62
45.21 ± 1105
Post-Occlusion
1.87 ± 2.17'
0.04 ± 5.01'
26.29 ± 843
13.43 ± 5.95
20.80 ± 9.25
19.56 ± 5.05
Reperfusion
44.17 ± 399
34.37 ± 498
5.52 ± 915
14.79 ± 455
7.58 ± 7.02
18.02 ± 410
'p < 0.001
Thus, combination of antihistamine-steriod pretreatment and dipyridamole
vasodilation enables enhanced visualization of myocardial perfusion by re-
duced doses of EG without significant hemodynamic effects. This approach
may be of value in achieving myocardial opacification in patients with EG
without incurring side effects.
As the data showed, after LAD occlusion anteroseptal (1) and anterolat-
eral (2) segments showed a statistically significant loss (*p < 0.001) of their
preocclusion contrast echo VD change and it was recovered following reper-
fusion. In our study, MRX provided visual and VD delineation of myocardium
at risk and changes induced by reperfusion after IV injection.
Thus, the ultrasound contrast agent FS069 results in measurable, con-
sistent, and reproducible myocardial opacification when administered intra-
venously.
Howard C. Dittrich, Gary L. Bales, Britta A McFerran, Mary T. Kuvelas, Roberta
M. Hunt. Yigal Greener University of California, San Diego, CA; Molecular Biosysterns,
Inc. San Diego, CA
In order for myocardial contrast echocardiography to become clinically use-
ful, ultrasound contrast agents must result in reproducible opacification. We
therefore studied a new agent capable of producing myocardial opacification
when given intravenously. FS069, proteinaceous, gas-filled microspheres
(mean size range: 3.6-5.4 micron, concentration: 6.3-9.0 x 108/m11. was
administered to 10 closed-chest anesthetized dogs (20-29 kgl in doses of
0.4--0.7 ml at a rate of 0.3 mllsec into an internal jugular or cephalic vein.
Total volumes/dog were 28-54 ml. Transthoracic, parasternal short axis im-
ages were acquired using a Hewlett Packard Sonos 1500 and time-intensity
curves from gated images were generated from the anterior, septal, and lat-
eral left ventricular walls and cavity with an on-line system. The increase in
mean pixel intensity compared to baseline was measured. No changes in
heart rate, systemic blood pressure, or arterial blood gases attributable to
FS069 were detected. Myocardial opacification in multiple segments was
documented in 100% of injections. There was no significant difference in in-
tensity change between injections although there was a difference between
myocardial segments within the same injection.
Reproducibility of Myocardial Opacification Using
FS069, a New Intravenously Administered
Ultrasound Contrast Agent
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'p < 0.01 compared to PESDA
Thomas Porter, Feng Xie, Alan Kricsfeld. University ofNebraska Medical Centerm,
Omaha, Nebraska
Large concentrations of intravenous (IV) albumin microbubbles are capable
of producing visual anterior myocardial contrast (MC). This also results in
high left ventricular cavity contrast which prevents visualization of posterior
myocardium due to attenuation. Recently, MC following intravenous soni-
cated dextrose albumin has been possible by altering microbubble (MB) gas
composition to one with lower blood solubility and diffusivity due to their
higher molecular weight (MW). Since this preserves MB size in blood, we hy-
pothesized that lower doses of this contrast could produce the same MC ef-
fect with less cavity attenuation following intravenous injection. Accordingly,
we sonicated dextrose albumin with two different gases of different MW:
an evaporated fluorocarbon gas (perfluoropentane: MW 270 grams/mole
(PPSDA); or perfluoropropane MW 188 g/mole (PESDA)). A total of 30 intra-
venous doses of 0.015-0.060 mllkg of the two different samples were given
to open chest dogs under baseline conditions, during adenosine infusion
(140Ikg/min), during acute ischemia produced by a left circumflex stenosis
or occlusion, and finally during subsequent reperfusion of the circumflex ves-
sel. The peak myocardial videointensity (PMVI) and duration (in seconds) of
attenuation (AD) in the posterior wall of these two agents were compared.
PMVI in the anterior (AW) and posterior wall (PW) were measured following
each injection, as were left circumflex and left anterior descending flow rates
with a Transonic Doppler. Values are mean ± standard deviation:
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Cavity
16.8 ± 66
16.4±7.0
0.99"
2.2 ± 15
2.1 ± 2.4
0.86'
Lateral
05 ± 0.6 52 ± 4.6
0.5 ± 0.6 4.9 ± 4.5
0.48 0.94"
Anterior Septal
Intensity Change (mean ± SD)
Injection 1, dB
Injection 2, dB
1 vs. 2, r
, < 0.01," < 0001
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Jinping Xu, George A Pantely, Shuping Ge, Susan Grauer, Takahiro Shiota,
Zheng Gong, Xiaodong Zhou, David J. Sahn. Oregon Health Sciences University,
Portland, Oregon
The availability of new contrast agents capable of transpulmonary, left ven-
tricular and myocardial opacification after intravenous injection warrants
evaluation of their efficacy for assessing abnormalities of myocardium per-
fusion and results of intervention. In the present study, open chest epicardial
echocardiography(7 MHz)was performed during intravenous administration
of MRX 115, a new lipid contrast agent at a dose of 0.02 or 0.05 mllkg in 6
instrumented monkeys before and after acute LAD ligation and following
reperfusion. Visually apparent myocardial opacification was evident in all an-
imals for all IV injections of MRX before LAD occlusion without significant
hemodynamic effect. After LAD occlusion, a "filling defect" overlapping the
area with abnormal wall motion could be delineated and uptake of subse-
quently injected contrast could be demonstrated within 10 to 20 minutes fol-
lowing release of LAD occlusion. The peak videodensitometric (VD) changes
(256 unit scale) from baseline after IV MRX injection over each of 6 areas of
coronary perfusion areas on the LV short axis before and after LAD occlusion
and 20 minutes following release are shown (mean ± SE):
IV PPSDABaseline
Both agents produced visua/Iy evident and similar anterior myocardial con-
trast, but PESDA caused prolonged posterior wall attenuation and failed to
produce significant posterior wall contrast. The dextrose albumin sonicated
with the gas of highest MW (PPSDA) produced significantly higher posterior
wall contrast (see example) which also improved the detection of area at risk
during LCX ischemia. We conclude that dextrose albumin sonicated with an
evaporated larger molecular weight fluorocarbon gas results in (a) improved
myocardial contrast of the posterior leftventricularwall with significantly less
attenuation; and (b) visual determination of the area at risk during posterior
ischemia.
Intracardiac Echocardiographic Quantification
and Monitoring of Myocardial Perfusion Defects
and Repertusion with the Use of Intravenous
Injection of FS069, a Transpulmonic Contrast
Agent
Steven Schwartz, Oi-Ling Cao, Alain Delabays, Lissa Sugeng, Natesa Pandian.
Tufts-New England Medical Cente" Boston, Massachusetts
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Contrast Echocardiographic Assessment of
Myocardial Pertusion Following Acute Coronary
Artery Occlusion and Repertusion Using
Intravenous Injection of Aerosome,. MRX 115 in
Monkeys
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Despite major efforts, echocardiographic delineation of LV myocardial hy-
